UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Using the HEMOCLOT direct thrombin inhibitor assay to determine plasma concentrations of dabigatran

Blood coagulation & fibrinolysis, 2012-03, Vol.23 (2), p.138-143

2012

Volltextzugriff (PDF)

Dabigatran etexilate--a novel, reversible, oral direct thrombin inhibitor: interpretation of coagulation assays and reversal of anticoagulant activity

Thrombosis and haemostasis, 2010-06, Vol.103 (6), p.1116-1127

2010

Volltextzugriff (PDF)

Nongenomic Steroid Action: Controversies, Questions, and Answers

Physiological reviews, 2003-07, Vol.83 (3), p.965-1016

2003

Volltextzugriff (PDF)

Dabigatran versus Warfarin for Acute Venous Thromboembolism in Elderly or Impaired Renal Function Patients: Pooled Analysis of RE-COVER and RE-COVER II

Thrombosis and haemostasis, 2017, Vol.117 (11), p.2045-2052

2017

Volltextzugriff (PDF)

Treatment with dabigatran or warfarin in patients with venous thromboembolism and cancer

Thrombosis and haemostasis, 2015, Vol.114 (1), p.150-157

2015

Volltextzugriff (PDF)

Type of anaesthesia and the safety and efficacy of thromboprophylaxis with enoxaparin or dabigatran etexilate in major orthopaedic surgery: pooled analysis of three randomized controlled trials

Thrombosis journal, 2012-06, Vol.10 (1), p.9-9

2012

Volltextzugriff (PDF)

Rapid Nongenomic Effects of Aldosterone in Mineralocorticoid-Receptor-Knockout Mice

Biochemical and biophysical research communications, 1999-12, Vol.266 (1), p.257-261

1999

Volltextzugriff (PDF)

Treatment of venous thromboembolism - effects of different therapeutic strategies on bleeding and recurrence rates and considerations for future anticoagulant management

Thrombosis journal, 2012-12, Vol.10 (1), p.24-24

2012

Volltextzugriff (PDF)

The discovery of dabigatran etexilate for the treatment of venous thrombosis

Expert opinion on drug discovery, 2016-07, Vol.11 (7), p.717-731

2016

Volltextzugriff (PDF)

The phosphodiesterase 4 inhibitor roflumilast is effective in the treatment of allergic rhinitis

Journal of allergy and clinical immunology, 2001-10, Vol.108 (4), p.530-536

2001

Volltextzugriff (PDF)

Integrating new approaches to atrial fibrillation management: the 6th AFNET/EHRA Consensus Conference

Europace (London, England), 2018-03, Vol.20 (3), p.395-407

2018

Volltextzugriff (PDF)

Efficacy of dabigatran versus warfarin in patients with acute venous thromboembolism in the presence of thrombophilia: Findings from RE-COVER®, RE-COVER™ II, and RE-MEDY

Vascular medicine (London, England), 2016-12, Vol.21 (6), p.506-514

2016

Volltextzugriff (PDF)

Treatment of acute pulmonary embolism with dabigatran versus warfarin. A pooled analysis of data from RE-COVER and RE-COVER II

Thrombosis and haemostasis, 2016-10, Vol.116 (4), p.714-721

2016

Volltextzugriff (PDF)

Multiple actions of steroid hormones--a focus on rapid, nongenomic effects

Pharmacological reviews, 2000-12, Vol.52 (4), p.513

2000

Volltextzugriff (PDF)

Dabigatran Is Associated with a Significantly Lower Risk of Abnormal Uterine Bleeding Than Warfarin in Female Patients of Childbearing Age with Venous Thromboembolism

Blood, 2016-12, Vol.128 (22), p.140-140

2016

Volltextzugriff (PDF)

Health technology assessment and its role in the future development of the Indian healthcare sector

Perspectives in clinical research, 2012-04, Vol.3 (2), p.66-72

2012

Volltextzugriff (PDF)

Bleeding events with dabigatran or warfarin in patients with venous thromboembolism

Thrombosis and haemostasis, 2016, Vol.115 (2), p.291-298

2016

Volltextzugriff (PDF)

Dalteparin dose-dependently increases ROTEM® thrombelastography parameters only at supratherapeutic anti-factor Xa levels: An in vitro study

Clinical and experimental pharmacology & physiology, 2011-11, Vol.38 (11), p.783-786

2011

Volltextzugriff (PDF)

Effectiveness and outcome of management strategies for dabigatran- or warfarin-related major bleeding events

Thrombosis research, 2016-04, Vol.140, p.81-88

2016

Volltextzugriff (PDF)

Dabigatran Etexilate or Warfarin in the Treatment of Acute Venous Thromboembolism in Western European Patients: A Pooled Analysis of RE-COVER® and RE-COVER II

Blood, 2015-12, Vol.126 (23), p.4730-4730

2015

Volltextzugriff (PDF)

Abstract 12422: Influence of Polypharmacy on the Efficacy And Safety Of Dabigatran Versus Warfarin for the Treatment of Acute Venous Thromboembolism: A Pooled Analysis of RE-COVER® and RE-COVER II

Circulation (New York, N.Y.), 2015-11, Vol.132 (Suppl_3 Suppl 3), p.A12422-A12422

2015

Volltextzugriff (PDF)

An open-label study of the pharmacokinetics and pharmacodynamics of dabigatran etexilate 150 mg once daily in Caucasian patients with moderate renal impairment undergoing primary unilateral elective total knee or hip replacement surgery

Thrombosis research, 2016-08, Vol.144, p.158-164

2016

Volltextzugriff (PDF)

Safety and efficacy of switching from low molecular weight heparin to dabigatran in patients undergoing elective total hip or knee replacement surgery

Thrombosis journal, 2015-11, Vol.13 (1), p.37-37, Article 37

2015

Volltextzugriff (PDF)

Dalteparin dose-dependently increases ROTEM® thrombelastography parameters only at supratherapeutic anti-factor Xa levels: An in vitro study: Dalteparin increases ROTEM® parameters

Clinical and experimental pharmacology & physiology, 2011-11, Vol.38 (11), p.783-786

2011

Volltextzugriff (PDF)

Oral dabigatran etexilate versus enoxaparin for venous thromboembolism prevention after total hip arthroplasty: pooled analysis of two phase 3 randomized trials

Thrombosis journal, 2015-11, Vol.13 (35), p.36-36, Article 36

2015

Volltextzugriff (PDF)

1 – 25 von 81

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(78)
Mit Volltextzugriff
(69)

Publikationsform

Artikel
(80)
magazinearticle
(1)

Sprache

Englisch
(79)
Deutsch
(2)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(44)
Science & Technology
(44)
Humans
(36)
Hematology
(22)
Male
(22)
Cardiovascular System & Cardiology
(20)
Biological And Medical Sciences
(19)
Female
(17)
Peripheral Vascular Disease
(17)
Adult
(16)
Dabigatran Etexilate
(15)
Middle Aged
(15)
Venous Thromboembolism
(15)
Aged
(13)
Medical Sciences
(13)
Dabigatran
(10)
Fundamental And Applied Biological Sciences. Psychology
(10)
Animals
(9)
Bleeding
(9)
Treatment Outcome
(9)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Using the HEMOCLOT direct thrombin inhibitor assay to determine plasma concentrations of dabigatran

Dabigatran etexilate--a novel, reversible, oral direct thrombin inhibitor: interpretation of coagulation assays and reversal of anticoagulant activity

Nongenomic Steroid Action: Controversies, Questions, and Answers

Dabigatran versus Warfarin for Acute Venous Thromboembolism in Elderly or Impaired Renal Function Patients: Pooled Analysis of RE-COVER and RE-COVER II

Treatment with dabigatran or warfarin in patients with venous thromboembolism and cancer

Type of anaesthesia and the safety and efficacy of thromboprophylaxis with enoxaparin or dabigatran etexilate in major orthopaedic surgery: pooled analysis of three randomized controlled trials

Rapid Nongenomic Effects of Aldosterone in Mineralocorticoid-Receptor-Knockout Mice

Treatment of venous thromboembolism - effects of different therapeutic strategies on bleeding and recurrence rates and considerations for future anticoagulant management

The discovery of dabigatran etexilate for the treatment of venous thrombosis

The phosphodiesterase 4 inhibitor roflumilast is effective in the treatment of allergic rhinitis

Integrating new approaches to atrial fibrillation management: the 6th AFNET/EHRA Consensus Conference

Efficacy of dabigatran versus warfarin in patients with acute venous thromboembolism in the presence of thrombophilia: Findings from RE-COVER®, RE-COVER™ II, and RE-MEDY

Treatment of acute pulmonary embolism with dabigatran versus warfarin. A pooled analysis of data from RE-COVER and RE-COVER II

Multiple actions of steroid hormones--a focus on rapid, nongenomic effects

Dabigatran Is Associated with a Significantly Lower Risk of Abnormal Uterine Bleeding Than Warfarin in Female Patients of Childbearing Age with Venous Thromboembolism

Health technology assessment and its role in the future development of the Indian healthcare sector

Bleeding events with dabigatran or warfarin in patients with venous thromboembolism

Dalteparin dose-dependently increases ROTEM® thrombelastography parameters only at supratherapeutic anti-factor Xa levels: An in vitro study

Effectiveness and outcome of management strategies for dabigatran- or warfarin-related major bleeding events

Dabigatran Etexilate or Warfarin in the Treatment of Acute Venous Thromboembolism in Western European Patients: A Pooled Analysis of RE-COVER® and RE-COVER II

Abstract 12422: Influence of Polypharmacy on the Efficacy And Safety Of Dabigatran Versus Warfarin for the Treatment of Acute Venous Thromboembolism: A Pooled Analysis of RE-COVER® and RE-COVER II

An open-label study of the pharmacokinetics and pharmacodynamics of dabigatran etexilate 150 mg once daily in Caucasian patients with moderate renal impairment undergoing primary unilateral elective total knee or hip replacement surgery

Safety and efficacy of switching from low molecular weight heparin to dabigatran in patients undergoing elective total hip or knee replacement surgery

Dalteparin dose-dependently increases ROTEM® thrombelastography parameters only at supratherapeutic anti-factor Xa levels: An in vitro study: Dalteparin increases ROTEM® parameters

Oral dabigatran etexilate versus enoxaparin for venous thromboembolism prevention after total hip arthroplasty: pooled analysis of two phase 3 randomized trials

Suchergebnisse filtern